n | Group | P | ||
---|---|---|---|---|
APOE ε4ε4 | APOE ε4ε3 | APOE ε3ε3 | ||
19 | 21 | 20 | ||
Age (years), mean (SD) | 67.3 (4.74) | 67.3 (4.90) | 68.3 (4.55) | 0.75 |
Sex (M/F), n (%) | 7/12 (37/63) | 7/14 (33/67) | 8/12 (40/60) | 0.91 |
Education, n (%) | 0.37 | |||
Primary school | 7 (37) | 4 (19) | 7 (35) | |
Middle or comprehensive school | 4 (21) | 4 (19) | 3 (15) | |
High school | 7 (37) | 6 (29) | 7 (35) | |
College or university | 1 (5) | 7 (33) | 3 (15) | |
BMI (kg/m2), mean (SD) | 26.6 (4.48) | 26.7 (3.46) | 27.3 (4.96) | 0.86 |
CERAD total score, mean (SD) | 84.4 (9.43) | 85.9 (7.98) | 86.0 (7.42) | 0.79 |
MMSE, median (IQR) | 28 (27–29) | 29 (28–30)a | 29 (27–30) | 0.040 |
Total leukocyte count (E9/L), mean (SD) | 5.38 (1.20) | 5.70 (1.68) | 5.22 (0.87) | 0.49 |
11C-PIB positivity, n (%) | 16 (84) | 10 (48) | 8 (40) | 0.0084 |
Computed Fazekas score, median (IQR) | 1.09 (0.98) | 0.92 (0.62) | 0.82 (0.79) | 0.80 |
11C-PIB composite SUVR, median (IQR) | 2.13 (1.61–2.83) | 1.55 (1.43–2.02) | 1.47 (1.38–1.66)a | 0.0024 |
11C-PK11195 composite DVR, mean (SD) | 1.34 (0.77) | 1.33 (0.052) | 1.31 (0.058) | 0.30 |